Let AI watch the worldβs key changes for you unkAI
unkAI continuously tracks the public intelligence and global changes you care about, and only alerts you when noteworthy new developments emerge. Subscribe for free by email β no repeated interruptions, no missed key changes.
Health
72 items Β· Recommended
U.S. FDA approval timeline for Novo Nordisk's CagriSema
Follow the FDA review progress of Novo Nordisk's combination weight loss drug CagriSema, track the PDUFA date, approval result and approved indication scope.
Dynamics of clinical application of shoulder arthroplasty surgical robots in China
Observing changes in marketing approval, clinical application effects and promotion scope of China's first shoulder arthroplasty surgical robot system
Dynamics of the implementation of Chinese herbal medicine insert specification in China
Follow up on the implementation of the Special Provisions on Traditional Chinese Medicine Registration after three years, and observe the rectification of unclear content and changes in re-registration results.
R&D and commercialization dynamics of personalized mRNA tumor vaccines
Track the progress of clinical trials, regulatory approval, indication expansion, mass production and commercial launch of personalized mRNA tumor vaccines.
Implementation dynamics of China's regulations on protecting the rights and interests of over-aged workers
Observe changes in employers' compliance adjustments and disputes over the implementation of rights protection after the implementation of the Interim Provisions on the Protection of Basic Rights and Interests of Over-aged Workers.
Changes in market supply of Chinese drugs removed from medical insurance after the transition period
Follow up on changes in market supply, price adjustment and patient accessibility of 8 drugs removed from the medical insurance catalog after the transition period ends.
Progress of rapid review of cell and gene therapy medicines in China
Follow up on changes in the approval progress of eligible cell and gene therapy medicines after the drug regulatory authority opened the rapid review channel for innovative drugs.
Global Commercialization Progress of Precision Cell Therapy
To observe the clinical application, pricing strategy, market penetration and iteration of industrial technology routes after the approval of precision cell therapies such as Orca-T.
New drug approval dynamics of China's National Medical Products Administration
Follow up the weekly new drug approval results of China's National Medical Products Administration, and focus on the approval dynamics and market impact in innovative drugs, anti-tumor drugs, medical devices and other fields.
Innovative drug prices and market dynamics after the implementation of China's medical insurance catalog
Focus on the admission progress, price adjustment, sales growth of newly added innovative drugs and their impact on corporate performance after the 2026 update of China's medical insurance catalog.
NMPA approval results of China's Class 1 innovative drugs
Follow up the approval process of Class 1 chemical innovative drugs entering the final stage of comprehensive review, focus on CDE review conclusions, NMPA administrative approval results and approval time.
Implementation progress of China's 15th Five-Year Plan for the revitalization and development of traditional Chinese medicine
Follow up the policy implementation of the "15th Five-Year Plan for the Revitalization and Development of Traditional Chinese Medicine", and focus on the progress of inheritance, innovation, modernization promotion and internationalization of traditional Chinese medicine.